Variant report
Variant | nsv516067 |
---|---|
Chromosome Location | chr8:119420259-119421020 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs4876823 | chr8:119420259-119420260 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs73311726 | chr8:119420273-119420274 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs140010290 | chr8:119420283-119420284 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs369222580 | chr8:119420328-119420329 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs4876824 | chr8:119420362-119420363 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
6 | rs4876825 | chr8:119420389-119420390 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs555629752 | chr8:119420396-119420397 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs115352011 | chr8:119420398-119420399 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs544515002 | chr8:119420409-119420410 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs10086502 | chr8:119420424-119420425 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
11 | rs73311730 | chr8:119420466-119420467 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs545311730 | chr8:119420494-119420495 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs10086524 | chr8:119420553-119420554 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs561827477 | chr8:119420555-119420556 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs527294688 | chr8:119420573-119420574 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs149806443 | chr8:119420579-119420580 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs370266967 | chr8:119420674-119420675 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs6985984 | chr8:119420714-119420715 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs7004302 | chr8:119420722-119420723 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs7004323 | chr8:119420775-119420776 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs375943145 | chr8:119420878-119420879 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs145754617 | chr8:119420944-119420945 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs376348732 | chr8:119420961-119420962 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs4876826 | chr8:119420999-119421000 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs4876827 | chr8:119421020-119421021 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Gastric cancer | 17908304 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Testicular cancer | 18059402 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
abnormal development | 18461090 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 17603634 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 21399628 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17393978 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Breast cancer | 17899364 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Breast cancer | 21611746 | CNVD |
Developmental delay | 21147756 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Congenital diaphragmatic hernia | 21525063 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Papillary thyroid cancer | 17515504 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Cancer | 20164920 | CNVD |
Breast cancer | 20932292 | CNVD |
Gastric cancer | 22539939 | CNVD |
Breast cancer | 22056952 | CNVD |
Langer-Giedion syndrome | 16773131 | CNVD |
Lung cancer | 16740712 | CNVD |
Mental retardation | 16773131 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Langer-Giedion syndrome | 22470819 | CNVD |
Cornelia de Lange syndrome | 24599119 | CNVD |
Gastric cancer | 21528007 | CNVD |
Breast cancer | 22532251 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21129771 | CNVD |
benign familial neonatal convulsions | 18472482 | CNVD |
Breast cancer | 16417655 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21183584 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Breast cancer | 20814816 | CNVD |
Colorectal cancer | 22486879 | CNVD |
Breast cancer | 17908964 | CNVD |
Colorectal cancer | 20031965 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Ovarian cancer | 17908964 | CNVD |
Ovarian cancer | 20031965 | CNVD |
Prostate cancer | 20031965 | CNVD |
Non-small cell lung cancer | 17643093 | CNVD |
Prostate cancer | 19242612 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Oral squamous cell carcinoma | 21853135 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Breast cancer | 18698023 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Uveal melanoma | 20484589 | CNVD |
head and neck squamous cell carcinoma | 16740747 | CNVD |
Breast cancer | 19181860 | CNVD |
Endometrial cancer | 23636398 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Breast cancer | 16397240 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Prostate cancer | 22341455 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20164919 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:119398800-119422000 | Weak transcription | GM12878-XiMat | blood |
2 | chr8:119413600-119431400 | Weak transcription | Sigmoid Colon | Sigmoid Colon |
3 | chr8:119419400-119420600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
4 | chr8:119419800-119420800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
5 | chr8:119419800-119420800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
6 | chr8:119420000-119420400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
7 | chr8:119420000-119420600 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
8 | chr8:119420000-119420600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
9 | chr8:119420000-119420600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
10 | chr8:119420000-119420600 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
11 | chr8:119420200-119420600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
12 | chr8:119420200-119420600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
13 | chr8:119420200-119420600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
14 | chr8:119420600-119425600 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
15 | chr8:119420600-119425600 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
16 | chr8:119420600-119426000 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
17 | chr8:119420600-119427200 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
18 | chr8:119420600-119431200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
19 | chr8:119420800-119425800 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
20 | chr8:119420800-119426000 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |